SCHEMBL865571

SCHEMBL865571

Nc1cccc2c1C(=O)c1cccc(-c3ccc(N)c4c3C(=O)c3ccccc3C4=O)c1C2=O

nearest known ligand 0.75

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ADORA2A P29274 5/20 0.75
MAOA P21397 3/20 0.70
CSNK1A1 P48729 2/20 0.70
CSNK1D P48730 2/20 0.70
CSNK1G1 Q9HCP0 2/20 0.70
FGR P09769 1/20 0.70
PIM1 P11309 1/20 0.70
DYRK1A Q13627 1/20 0.70
HIPK2 Q9H2X6 1/20 0.70
PTPRC P08575 1/20 0.63
MAOB P27338 1/20 0.59
MEN1 O00255 9/20 0.58
KMT2A Q03164 9/20 0.58
ALDH1A1 P00352 7/20 0.58
MAPT P10636 7/20 0.58
POLB P06746 6/20 0.58
MCL1 Q07820 5/20 0.58
SMN1; SMN2 Q16637 4/20 0.58
L3MBTL1 Q9Y468 4/20 0.58
TDP1 Q9NUW8 3/20 0.58

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31174159 1.00 ADORA2A (0.75) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL29548552 0.90 ADORA2A (0.86) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL278755 0.90 ADORA2A (0.86) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL29529563 0.90 ADORA2A (0.86) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL29701006 0.86 ADORA2A (1.00) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
Anthraquinone SCHEMBL11781807 0.86 ADORA2A (1.00) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL1557667 0.86 ADORA2A (1.00) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL26348 0.86 ADORA2A (1.00) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL732084 0.86 ADORA2A (0.83) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1
SCHEMBL3177072 0.86 ADORA2A (0.76) ADORA2AMAOACSNK1A1CSNK1DCSNK1G1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 41 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250180952-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2025-06-05 US disclosed
US-11634544-B2 Photoaligning materials Rolic Technologies AG (CH) 2023-04-25 US disclosed
US-20210340330-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2021-11-04 US disclosed
US-20200223984-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2020-07-16 US disclosed
US-10696795-B2 Photoaligning materials Rolic Technologies AG (CH) 2020-06-30 US disclosed
EP-3374467-B1 COMPOSITIONS OF PHOTO-ALIGNABLE MATERIALS ROLIC TECH AG (CH) 2020-04-15 EP disclosed
US-10558089-B2 Photoalignment composition ROLIC AG (CH) 2020-02-11 US disclosed
EP-2222815-B1 PHOTOALIGNMENT COMPOSITION ROLIC TECH AG (CH) 2019-05-29 EP disclosed
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group ROLIC AG (CH) 2019-02-19 US disclosed
US-20180319939-A1 PHOTOALIGNING MATERIALS Rolic Technologies AG (CH) 2018-11-08 US disclosed
US-20120076952-A1 PHOTOCROSSLINKABLE MATERIALS ROLIC AG (CH) 2012-03-29 US disclosed
EP-2308827-A1 Photocrosslinkable materials Rolic AG (CH) 2011-04-13 EP disclosed
EP-2308826-A1 Photocrosslinkable materials Rolic AG (CH) 2011-04-13 EP disclosed
EP-2305632-A1 Photocrosslinkable materials Rolic AG (CH) 2011-04-06 EP disclosed
EP-2305631-A1 Photocrosslinkable materials Rolic AG (CH) 2011-04-06 EP disclosed
US-20100266814-A1 PHOTOALIGNMENT COMPOSITION ROLIC AG (CH) 2010-10-21 US disclosed
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2010-02-25 US disclosed
EP-2152660-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP Rolic AG (CH) 2010-02-17 EP disclosed
WO-2008145225-A2 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP ROLIC AG (CH) 2008-12-04 WO disclosed
US-20080293888-A1 Photocrosslinkable Materials ROLIC AG (CH) 2008-11-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10208031-B2 Photocrosslinkable materials comprising alicyclic group DDC, ALAD, DYNC1LI1 ADORA2A 2659/4885MAOA 588/4885CSNK1A1 3825/4885
US-20100048849-A1 PHOTOCROSSLINKABLE MATERIALS COMPRISING ALICYCLIC GROUP DDC, ALAD, DYNC1LI1 ADORA2A 2659/4885MAOA 588/4885CSNK1A1 3825/4885
US-20080293888-A1 Photocrosslinkable Materials DDC, PARG, ALAD ADORA2A 3190/4885MAOA 285/4885CSNK1A1 3719/4885
US-20120076952-A1 PHOTOCROSSLINKABLE MATERIALS DDC, PARG, ALAD ADORA2A 3190/4885MAOA 285/4885CSNK1A1 3719/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.